Getting ahead of regulatory changes around PFAS in pharmaceutical packaging
Clarivate
MARCH 14, 2024
With the introduction of a new CMC Intelligence entitlement to address post-approval changes, Clarivate now covers a broader range of the lifecycle of pharmaceutical products. A chance to innovate: Global health impacts our world and there are various stakeholders making choices, from manufacturers to healthcare providers and patients.
Let's personalize your content